tiprankstipranks
Trending News
More News >
Quest Diagnostics: Steady Growth and Strategic Advancements Justify Buy Rating
PremiumRatingsQuest Diagnostics: Steady Growth and Strategic Advancements Justify Buy Rating
1M ago
Quest Diagnostics: Resilient Investment with Strategic Growth Initiatives and Strong Financials
Premium
Ratings
Quest Diagnostics: Resilient Investment with Strategic Growth Initiatives and Strong Financials
1M ago
Quest Diagnostics price target raised to $191 from $190 at Baird
Premium
The Fly
Quest Diagnostics price target raised to $191 from $190 at Baird
1M ago
Quest Diagnostics reaffirms FY25 adjusted EPS view $9.55-$9.80, consensus $9.71
PremiumThe FlyQuest Diagnostics reaffirms FY25 adjusted EPS view $9.55-$9.80, consensus $9.71
1M ago
Positive Outlook for Quest Diagnostics: Buy Rating Supported by Strong Growth and Strategic Initiatives
Premium
Ratings
Positive Outlook for Quest Diagnostics: Buy Rating Supported by Strong Growth and Strategic Initiatives
1M ago
Quest Diagnostics to hold an investor day
Premium
The Fly
Quest Diagnostics to hold an investor day
1M ago
Okta upgraded, Quest Diagnostics downgraded: Wall Street’s top analyst calls
PremiumThe FlyOkta upgraded, Quest Diagnostics downgraded: Wall Street’s top analyst calls
2M ago
Quest Diagnostics downgraded to Neutral from Buy at Citi
Premium
The Fly
Quest Diagnostics downgraded to Neutral from Buy at Citi
2M ago
Fresenius Medical divesting select laboratory assets to Quest Diagnostics
Premium
The Fly
Fresenius Medical divesting select laboratory assets to Quest Diagnostics
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100